摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

benzyl ethyl chlorophosphate | 73992-66-2

中文名称
——
中文别名
——
英文名称
benzyl ethyl chlorophosphate
英文别名
O-ethyl benzylchlorophosphonate;[chloro(ethoxy)phosphoryl]oxymethylbenzene
benzyl ethyl chlorophosphate化学式
CAS
73992-66-2
化学式
C9H12ClO3P
mdl
——
分子量
234.619
InChiKey
HGXCPASPLWDAKG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    325.9±21.0 °C(Predicted)
  • 密度:
    1.254±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    14
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Zwitterionic analogs of cimetidine as H2 receptor antagonists
    摘要:
    A series of analogues of the H2 receptor histamine antagonist cimetidine have been synthesized in which the dipolar cyanoguanidine group has been replaced by a number of zwitterionic moieties. Although none of the compounds is more effective than cimetidine in blocking histamine-stimulated tachycardia on the isolated guinea pig atrium, the activities of most of the compounds possessing rigid dipoles can be accounted for on the basis of dipole orientation relative to the common side chain and by considering the active species in each case to be the zwitterion. These findings are in general agreement with those found for analogues having conjugated groups as dipoles.
    DOI:
    10.1021/jm00390a006
  • 作为产物:
    描述:
    Ethyl-benzyl-phosphit磺酰氯 作用下, 以 四氯化碳 为溶剂, 反应 1.0h, 生成 benzyl ethyl chlorophosphate
    参考文献:
    名称:
    New Synthesis of Phosphorous and Phosphoric Acid Esters
    摘要:
    在四烷氧基钛的存在下,醇与二烷基亚磷酸酯反应,会导致所用醇的 RO 基团取代两个或一个酯官能团。用这种方法制备的混合亚磷酸酯 (R3O)(R1O)P(O)H 可用作混合磷酸盐 (R4O)(R3O)(R1O)PO 的底物。
    DOI:
    10.1055/s-1991-26418
点击查看最新优质反应信息

文献信息

  • Amidines, their preparation and pharmaceutical compositions containing them.
    申请人:SMITH KLINE & FRENCH LABORATORIES LIMITED
    公开号:EP0007326A1
    公开(公告)日:1980-02-06
    Amidine phosphonate compounds have the structure in which Het is a 5- or 6- membered unsaturated nitrogen heterocycle, Z is sulphur or methylene, n is 2 or 3, R' is hydrogen, lower alkyl or Het-CH2Z(CH2)n2-, p is 0 or 1, R2 is hydrogen or lower alkyl, or R' and R2 together form a (CH2)2 or(CH2)3 group, R'is lower alkyl, aryl or aryl-(lower alkyl), and R4 is hydrogen when p is 0 and hydrogen, lower alkyl, aryl or aryl (lower alkyl) when p is 1. Those compounds where R4 is other than hydrogen are intermediates for the preparation of the compounds where R4 is hydrogen, which have histamine H2-antagonist activity and are the active ingredients of pharmaceutical compositions. The compounds are prepared by primary amine coupling reactions, phosphonylation and hydrolysis.
    膦酸脒化合物的结构如下 其中 Het 是 5 或 6 位不饱和氮杂环,Z 是硫或亚甲基,n 是 2 或 3,R'是氢、低级烷基或 Het-CH2Z(CH2)n2-,p 是 0 或 1,R2 是氢或低级烷基、或 R' 和 R2 共同形成 (CH2)2 或 (CH2)3 基团,R'为低级烷基、芳基或芳基(低级烷基),当 p 为 0 时,R4 为氢,当 p 为 1 时,R4 为氢、低级烷基、芳基或芳基(低级烷基)。R4不是氢的化合物是制备R4是氢的化合物的中间体,这些化合物具有组胺H2-拮抗剂活性,是药物组合物的活性成分。这些化合物是通过伯胺偶联反应、膦酰化反应和水解反应制备的。
  • Covalent Inhibition of Serine β-Lactamases by Novel Hydroxamic Acid Derivatives
    作者:Ronak Tilvawala、R. F. Pratt
    DOI:10.1021/bi4003887
    日期:2013.5.28
    The effectiveness of beta-lactam antibiotics is greatly limited by the ability of bacteria to produce beta-lactamases. These enzymes catalyze the hydrolysis of beta-lactams and thus loss of their antibiotic activity. The search for inhibitors of beta-lactamases began soon after beta-lactams were introduced into medical practice and continues today. Some time ago, we introduced a new class of covalent serine beta-lactamase inhibitors, the O-aryloxycarbonyl hydroxamates, that inactivated these enzymes by a unique mechanism in which the active site became cross-linked. We describe in this paper some new variants of this class of inhibitor. First, we investigated compounds in which more polar hydroxamates were incorporated. These were generally not more active than the original compounds against representative class A and class C beta-lactamases, but one of them, 1-(benzoyl)-O-(phenoxycarbonyl)-3-hydroxyurea, was significantly more stable in solution, thus revealing a useful platform for further design. Second, we describe a series of O-(arylphosphoryl) hydroxamates that are also irreversible inactivators of class A and class C beta-lactamases, by phosphorylation of the enzyme, as revealed by mass spectra. These compounds did not, however, cross-link the enzyme active site A striking feature of their structure-activity profile was that hydroxamate remained the leaving group on enzyme phosphorylation rather than aryloxide, even though the aryloxide was intrinsically the better leaving group, as indicated by pK(a) values and demonstrated by the products of hydrolysis in free solution. Model building suggested that this phenomenon arises from the relative affinity of the enzyme active site components for the two leaving groups. The results obtained for both groups of inhibitors are important for further optimization of these inhibitors.
  • US4190664A
    申请人:——
    公开号:US4190664A
    公开(公告)日:1980-02-26
  • US4282213A
    申请人:——
    公开号:US4282213A
    公开(公告)日:1981-08-04
  • Zwitterionic analogs of cimetidine as H2 receptor antagonists
    作者:Rodney C. Young、C. Robin Ganellin、Michael J. Graham、Robert C. Mitchell、Michael L. Roantree、Zev Tashma
    DOI:10.1021/jm00390a006
    日期:1987.7
    A series of analogues of the H2 receptor histamine antagonist cimetidine have been synthesized in which the dipolar cyanoguanidine group has been replaced by a number of zwitterionic moieties. Although none of the compounds is more effective than cimetidine in blocking histamine-stimulated tachycardia on the isolated guinea pig atrium, the activities of most of the compounds possessing rigid dipoles can be accounted for on the basis of dipole orientation relative to the common side chain and by considering the active species in each case to be the zwitterion. These findings are in general agreement with those found for analogues having conjugated groups as dipoles.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐